Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Frauger

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
International Clinical Psychopharmacology|October 13, 2009
Estimation of clonazepam abuse liability: a new method using a reimbursed drug databaseElisabeth Frauger, Vanessa Pauly, Xavier Thirion, et al.
British Journal of Clinical Pharmacology|March 23, 2022
Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance dataAnne Roussin, Thomas Soeiro, Charlotte Fouque, et al.
Pain Physician|January 24, 2013
Doctor shopping reveals geographical variations in opioid abuseSandra Nordmann, Vincent Pradel, Maryse Lapeyre-Mestre, et al.
European Addiction Research|October 23, 2015
Patterns of Methylphenidate Use and Assessment of Its Abuse among the General Population and Individuals with Drug DependenceElisabeth Frauger, Despina Amaslidou, Michel Spadari, et al.
Drug and Alcohol Dependence|August 10, 2010
Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuseVanessa Pauly, Elisabeth Frauger, Vincent Pradel, et al.
International Clinical Psychopharmacology|August 11, 2011
Monitoring of benzodiazepine diversion using a multi-indicator approachVanessa Pauly, Elisabeth Frauger, Vincent Pradel, et al.
Fundamental & Clinical Pharmacology|August 28, 2020
Health consequences of cocaine use in France: data from the French Addictovigilance NetworkCéline Eiden, Marc Vincent, Chris Serrand, et al.
Therapie|December 13, 2019
[French trends in the misuse of Fentanyl: From 2010 to 2015]Juliana Tournebize, Valérie Gibaja, Elisabeth Frauger, et al.
Therapie|November 13, 2024
From regional signal to alert in addictovigilanceAmélie Daveluy, Justine Perino, Valérie Gibaja, et al.
Therapie|July 3, 2016
[The current aspects of the use of ecstasy/MDMA in France]Michel Spadari, Anne Batisse, Marylène Guerlais, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
International Clinical Psychopharmacology|October 13, 2009
Estimation of clonazepam abuse liability: a new method using a reimbursed drug databaseElisabeth Frauger, Vanessa Pauly, Xavier Thirion, et al.
British Journal of Clinical Pharmacology|March 23, 2022
Increase of high-risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance dataAnne Roussin, Thomas Soeiro, Charlotte Fouque, et al.
Pain Physician|January 24, 2013
Doctor shopping reveals geographical variations in opioid abuseSandra Nordmann, Vincent Pradel, Maryse Lapeyre-Mestre, et al.
European Addiction Research|October 23, 2015
Patterns of Methylphenidate Use and Assessment of Its Abuse among the General Population and Individuals with Drug DependenceElisabeth Frauger, Despina Amaslidou, Michel Spadari, et al.
Drug and Alcohol Dependence|August 10, 2010
Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuseVanessa Pauly, Elisabeth Frauger, Vincent Pradel, et al.
International Clinical Psychopharmacology|August 11, 2011
Monitoring of benzodiazepine diversion using a multi-indicator approachVanessa Pauly, Elisabeth Frauger, Vincent Pradel, et al.
Fundamental & Clinical Pharmacology|August 28, 2020
Health consequences of cocaine use in France: data from the French Addictovigilance NetworkCéline Eiden, Marc Vincent, Chris Serrand, et al.
Therapie|December 13, 2019
[French trends in the misuse of Fentanyl: From 2010 to 2015]Juliana Tournebize, Valérie Gibaja, Elisabeth Frauger, et al.
Therapie|November 13, 2024
From regional signal to alert in addictovigilanceAmélie Daveluy, Justine Perino, Valérie Gibaja, et al.
Therapie|July 3, 2016
[The current aspects of the use of ecstasy/MDMA in France]Michel Spadari, Anne Batisse, Marylène Guerlais, et al.
Pageof 6